Font: Financial Modeling Prep • Apr 01, 2026
Nike Inc (NYSE:NKE, XETRA:NKE) recently faced a significant drop in its share price, falling over 14% on Wednesday. This decline came after the company reported unchanged quarterly revenue compared to the previous year and issued a cautious outlook for the upcoming months. Nike's guidance for the fourth quarter anticipates a revenue decline of 2% to 4%, which contrasts with Wall Street analysts' expectations of a 2% growth.
For the quarter ending February 28, Nike reported revenue of $11.28 billion. This figure was flat on a reported basis and down 3% on a currency-neutral basis, slightly surpassing the consensus estimate of $11.23 billion. Wholesale sales increased by 5% to $6.5 billion, while Nike Direct revenue decreased by 4% to $4.5 billion. The decline in Nike Direct revenue was attributed to weaker digital sales and lower performance at company-owned stores.
Despite these challenges, Nike's earnings per share of $0.35 exceeded the estimated $0.31. However, the company's gross margin declined by 130 basis points to 40.2%, primarily due to higher tariffs in North America. Net income fell by 35% to $500 million, or $0.35 per diluted share. Regionally, North America saw modest growth of 3%, while Greater China experienced a 7% decline.
Additionally, Converse revenue dropped by 35%, reflecting declines across all markets. CEO Elliott Hill described the quarter as part of a broader effort to strengthen the business. He emphasized that while the work is ongoing, the company is making progress on prioritized initiatives. Hill stated, "The work is not finished, but the direction is clear, our teams are moving with focus and urgency, and our foundation is getting even stronger to build the future of NIKE."
|
GV§>
Visionary Holdings Inc.
|
$0.44
116.78%
|
|
LNKS§>
Linkers Industries Limited
|
$0.01
-35.16%
|
|
AIXI§>
Xiao-I Corporation
|
$0.13
33.10%
|
|
SKYQ§>
Sky Quarry Inc.
|
$5.10
101.58%
|
|
NVDA§>
NVIDIA Corporation
|
$177.39
0.93%
|
|
BITO§>
ProShares - Bitcoin ETF
|
$9.21
-1.60%
|
|
COCP§>
Cocrystal Pharma, Inc.
|
$1.51
48.04%
|
|
TSLL§>
Direxion Daily TSLA Bull 2X ETF
|
$11.37
-10.96%
|
|
SPDN§>
Direxion Daily S&P 500 Bear 1X ETF
|
$9.87
0.10%
|
|
BDRX§>
Biodexa Pharmaceuticals Plc
|
$0.87
42.23%
|